NYSE · CIK 0000012208 · LABORATORY ANALYTICAL INSTRUMENTS
BIO-RAD LABORATORIES, INC.
BIO chart by TradingView
PRICE HISTORY
LIVE · NYSEBIO chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $2.6B
- EBITDA
- $0.2B
- FREE CASH FLOW
- $0.4B
- EPS
- $27.85
- GROSS MARGIN
- 51.87%
- ROIC
- 9.35%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
35.4x
-31%3.4x516.1x
⤢
P / SALES (TTM)
3.0x
+29%2.4x7.8x
⤢
P / BOOK
1.1x
-39%0.9x2.4x
⤢
EV / EBITDA (TTM)
37.1x
-82%17.9x202.6x
⤢
EV / REVENUE (TTM)
3.2x
+2%2.9x7.7x
⤢
FCF YIELD (TTM)
4.49%
+3.8pp-0.10%5.65%
⤢
DIVIDEND YIELD (TTM)
—
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$0.7B
+28%⤢
EBITDA (DERIVED)
$0.1B
+109%⤢
NET INCOME
$0.4B
+1918%⤢
EPS (DILUTED)
$13.85
+2133%⤢
REVENUE GROWTH YOY
-0.09%
-8.3pp-9.76%33.35%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
10.25%
+7.9pp-19.11%31.08%
⤢
RETURN ON CAPITAL
2.98%
-6.1pp-65.75%46.03%
⤢
RETURN ON EQUITY (TTM)
3.10%
-0.4pp-71.02%43.48%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN53.12%
OPERATING MARGIN11.15%
NET MARGIN57.05%
FCF MARGIN10.25%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.1B
+449%⤢
STOCK-BASED COMP
$0.0B
+195%⤢
CAPITAL EXPENDITURE
$0.0B
-19%⤢
SHARES OUTSTANDING
0.03B
-10%⤢
DIVIDEND / SHARE
—
BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$0.5B
+24%⤢
TOTAL DEBT
$0.8B
+83%⤢
DEBT / EBITDA (TTM)
3.6x
-71%0.0x12.6x
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 92.36%INSIDERS 16.36%OTHER / RETAIL 0.00%529 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| First Eagle Investment Management, LLC | 12.02% | 2.6M | $918.6M | +0.1% |
| Blackrock Inc. | 7.75% | 1.7M | $592.2M | -0.1% |
| Dimensional Fund Advisors LP | 5.03% | 1.1M | $384.0M | +1.1% |
| Vanguard Capital Management LLC | 3.83% | 831K | $293.0M | NEW |
| Vanguard Portfolio Management LLC | 3.83% | 829K | $292.3M | NEW |
| Ariel Investments, LLC | 3.63% | 786K | $277.0M | +2.8% |
| Earnest Partners LLC | 2.72% | 589K | $207.5M | -2.5% |
| State Street Corporation | 2.58% | 560K | $197.2M | -0.0% |
| Capital World Investors | 2.08% | 450K | $158.6M | NEW |
| Bank of America Corporation | 2.05% | 445K | $156.8M | -0.1% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.